股票代码：600390 股票简称：五矿资本 公告编号：临2025-071 五矿资本股份有限公司 关于赎回"五资优 5"优先股的第二次提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2023 年 11 月 21 日，五矿资本股份有限公司（以下简称"公司"） 向特定对象成功发行 2,000 万股"五资优 5"优先股，优先股票面金 额合计 20 亿元，优先股代码为 360046，简称"五资优 5"。根据《五 矿资本股份有限公司向特定对象发行优先股募集说明书（第三期）》 的规定，在符合相关法律、法规、规范性文件的前提下，公司可根据 经营情况于优先股股息发放日全部或部分赎回注销本次发行的优先 股，赎回期至本次向特定对象发行的优先股全部赎回之日止。 2025 年 10 月 24 日，公司第九届董事会第二十七次会议审议通 过《关于五矿资本股份有限公司赎回"五资优 5"优先股的议案》， 现将赎回事项提示如下： 一、赎回规模 公司本期赎回已发行的"五资优 5"优先股股票 2,000 万股，票 面金额合计 20 亿元。 本期优先股的赎 ...

五矿资本股份有限公司 股票代码：600390 股票简称：五矿资本 编号：临2025-070 关于子公司2025年度第四期短期融资券发行结果公告 本 期 发 行 短 期 融 资 券 的 相 关 文 件 已 在 中 国 货 币 网 (www.chinamoney.com.cn) 和上海清算所网站(www.shclearing.com.cn) 上刊登。 特此公告。 五矿资本股份有限公司董事会 2025年11月6日 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 五矿资本股份有限公司（以下简称"公司"）控股子公司五矿证 券有限公司（以下简称"五矿证券"）2025年度第四期短期融资券已 于2025年11月4日发行完毕，相关发行情况如下： | 短期融资券名称 | | | | 五矿证券有限公司 | 2025 | 年度第四期短期融资券 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 短期融资券简称 | 25 五矿证券 | | CP004 | | 短 ...

五矿资本股份有限公司 2025 年第三次临时股东会 会议文件 二 ○ 二 五 年 十 一 月 2025 年第三次临时股东会会议须知 为了维护全体股东的合法权益，确保本次股东会公开、公正、合 法有效，保证会议顺利进行，根据《公司法》《公司章程》以及《股 东会议事规则》等相关法律法规和规定，特制定本须知，请出席股东 会的全体人员遵照执行。 1、本次股东会由董事会秘书负责会议的组织工作和处理相关事 宜。 2、参加本次股东会的股东或股东代表请按规定出示身份证或法 人单位证明以及授权委托书等证件，经查验合格后，方可出席会议。 为保证本次股东会的严肃性和正常秩序，切实维护与会股东（或股东 代表）的合法权益，除出席会议的股东（或股东代表）、公司董事、 高级管理人员、董事会办公室工作人员、公司聘请的律师以及公司董 事会邀请的人员外，公司有权拒绝其他人员进入会场。 3、会议正式开始后，迟到股东人数、股份额不计入表决权数。 特殊情况下，应经董事会秘书同意并向鉴证律师申报同意后方可计入 表决权数。 4、股东参加会议依法享有发言权、质询权、表决权等各项法定 权利，同时也应履行法定义务。事先准备并要求在会议发言的股东或 股东代表，应当 ...

Core Viewpoint - Wenkang Capital (600390.SH) reported a decline in total operating revenue and net profit for the third quarter, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved total operating revenue of 1.862 billion yuan in Q3, a year-on-year decrease of 7.71% [1] - The net profit attributable to shareholders was 229 million yuan, down 28.46% year-on-year [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 389 million yuan, showing a year-on-year increase of 21.67% [1] - Basic earnings per share were reported at 0.04 yuan [1]

关于续聘会计师事务所的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 证券代码：600390 证券简称：五矿资本 公告编号：临 2025-066 五矿资本股份有限公司 重要内容提示： 拟聘任的会计师事务所名称：中审众环会计师事务所 （特殊普通合伙）（以下简称"中审众环"） 一、拟聘任会计师事务所的基本情况 （一）机构信息 1.基本信息 （1）机构名称：中审众环会计师事务所（特殊普通合伙） （2）成立日期：中审众环始创于 1987 年，是全国首批取得国家 批准具有从事证券、期货相关业务资格及金融业务审计资格的大型会 计师事务所之一。根据财政部、证监会发布的从事证券服务业务会计 师事务所备案名单，中审众环具备股份有限公司发行股份、债券审计 机构的资格。2013 年 11 月，按照国家财政部等有关要求转制为特殊 普通合伙制。 （3）组织形式：特殊普通合伙企业 （4）注册地址：湖北省武汉市武昌区水果湖街道中北路 166 号 长江产业大厦 17-18 层。 （5）首席合伙人：石文先 （6）2024 年末合伙人数量 216 人、注册 ...

股票代码：600390 股票简称：五矿资本 公告编号：临2025-068 五矿资本股份有限公司 本期优先股的赎回价格为优先股票面金额（100 元/股）加当期已 决议支付但尚未支付的优先股股息。 三、赎回时间 "五资优 5"的固定股息发放日，即 2025 年 11 月 21 日。 公司于 2025 年 11 月 21 日向"五资优 5"优先股股东支付其所 持有的优先股票面金额（100 元/股）和 2024 年 11 月 21 日至 2025 年 11 月 20 日持有期间的固定股息。 关于赎回"五资优 5"优先股的第一次提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 2023 年 11 月 21 日，五矿资本股份有限公司（以下简称"公司"） 向特定对象成功发行 2,000 万股"五资优 5"优先股，优先股票面金 额合计 20 亿元，优先股代码为 360046，简称"五资优 5"。根据《五 矿资本股份有限公司向特定对象发行优先股募集说明书（第三期）》 的规定，在符合相关法律、法规、规范性文件的前提下，公司可根据 经营情 ...

证券代码：600390 证券简称：五矿资本 公告编号：2025-069 五矿资本股份有限公司 关于召开2025年第三次临时股东会的通知 (二)股东会召集人：董事会 (三)投票方式：本次股东会所采用的表决方式是现场投票和网络投票相结合的方 式 (四)现场会议召开的日期、时间和地点 2025年第三次临时股东会 召开的日期时间：2025 年 11 月 10 日 14 点 00 分 召开地点：北京市东城区工体北路新中西街 8 号亚洲大酒店二层锦义厅 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、 召开会议的基本情况 (一)股东会类型和届次 (五)网络投票的系统、起止日期和投票时间。 股东会召开日期：2025年11月10日 本次股东会采用的网络投票系统：上海证券交易所股东会网络投票系统 网络投票系统：上海证券交易所股东会网络投票系统 涉及融资融券、转融通业务、约定购回业务相关账户以及沪股通投资者 的投票，应按照《上海证券交易所上市公司自律监管指引第 1 号 — 规范运 作》等有关规定执行。 (七)涉及公开征集股东投 ...

Company Performance - Wenkang Capital reported a revenue of approximately 5.192 billion yuan for the first three quarters of 2025, representing a year-on-year decrease of 11.92% [1] - The net profit attributable to shareholders of the listed company was approximately 754 million yuan, down 38.05% year-on-year [1] - Basic earnings per share were 0.12 yuan, reflecting a decrease of 40% compared to the previous year [1] - As of the report date, Wenkang Capital's market capitalization stood at 26.9 billion yuan [1] Industry Insights - The Chinese innovative drug sector has seen significant overseas licensing sales, totaling 80 billion USD this year [1] - There is a contrast in the biopharmaceutical secondary market being active while the primary market is experiencing a fundraising slowdown [1]

Group 1 - The core point of the article is that Wukuang Capital (SH 600390) held its 27th meeting of the 9th board of directors on October 24, 2025, to discuss the reappointment of the auditing institution for the 2025 financial report and internal control [1] - For the first half of 2025, Wukuang Capital's revenue composition is as follows: leasing companies accounted for 37.21%, futures companies 28.15%, trust companies 17.16%, securities companies 15.13%, and other industries 2.33% [1] - As of the report date, Wukuang Capital has a market capitalization of 26.9 billion yuan [1] Group 2 - The article mentions that Chinese innovative drugs have sold overseas licenses worth 80 billion USD this year, highlighting the hot secondary market in biomedicine while questioning the cold fundraising environment in the primary market [1]

Financial Performance - Total operating income for Q3 2025 was CNY 1,861,888,269.10, a decrease of 7.71% compared to CNY 2,514,346,975.88 in the same period last year[6] - Net profit attributable to shareholders was CNY 228,820,359.34, down 28.46% from CNY 319,844,076.25 year-on-year[6] - Interest income decreased by 28.45% to CNY 740,705,316.89 from CNY 1,035,240,924.28 in the previous year[6] - The total profit for the quarter was CNY 234,635,670.57, down 49.33% from CNY 463,091,564.03 year-on-year[6] - Net profit attributable to shareholders for the year-to-date period decreased by 38.05%, mainly due to the transformation of the trust business and a reduction in commission income[12] - Basic earnings per share for Q3 2025 were CNY 0.04, a decrease of 20.00% from CNY 0.05 in the same period last year[6] - Basic earnings per share decreased by 40.00% year-to-date[12] - Net profit for the first three quarters of 2025 was CNY 889,936,616.81, down 43.14% from CNY 1,561,132,397.64 in 2024[26] - The company reported a total profit of CNY 993,684,167.00, down 48.93% from CNY 1,945,474,564.09 in 2024[26] Cash Flow - The net cash flow from operating activities for the year-to-date was CNY 2,235,682,704.25, down 66.55% compared to CNY 6,682,667,750.62 in the same period last year[6] - Cash flow from operating activities generated a net amount of CNY 2,235,682,704.25, a significant decrease from CNY 6,682,667,750.62 in the previous year[29] - Cash inflow from financing activities totaled $11.19 billion, up from $4.91 billion year-over-year[30] - Cash outflow from financing activities amounted to $12.66 billion, compared to $5.72 billion in the previous period[30] - Net cash flow from financing activities was -$1.47 billion, worsening from -$808.68 million year-over-year[30] - The net increase in cash and cash equivalents was $2.31 billion, down from $3.94 billion in the previous period[30] - The ending balance of cash and cash equivalents was $24.63 billion, slightly down from $24.82 billion year-over-year[30] Assets and Liabilities - Total assets as of the end of the reporting period were CNY 155,418,752,872.27, reflecting a decrease of 3.18% from the previous year-end[7] - The company's total assets of the company as of September 30, 2025, amounted to ¥155.42 billion, a decrease from ¥160.53 billion in the previous period[21] - Total liabilities increased to ¥101.15 billion from ¥98.76 billion, indicating a rise of about 2.3%[23] - The company's equity attributable to shareholders decreased to ¥44.39 billion from ¥52.03 billion, a decline of approximately 14.7%[23] - The company's total non-current assets decreased from ¥63.16 billion to ¥59.53 billion, a reduction of about 5.3%[22] - The company's total equity decreased from ¥61.77 billion to ¥54.27 billion, indicating a decline of approximately 12.1%[23] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 130,107[14] - The largest shareholder, China Minmetals Corporation, holds 2,117,064,042 shares, accounting for 47.07% of the total shares[14] - The total number of preferred shareholders at the end of the reporting period was 15[17] Revenue and Costs - Operating revenue for the current reporting period increased by 64.30% compared to the same period last year, primarily due to the growth of the subsidiary Wukuang[12] - Year-to-date operating revenue increased by 98.56%, driven by the expansion of the integrated business scale in industrial finance[12] - Total operating revenue for the first three quarters of 2025 was CNY 5,192,135,724.93, a decrease of 11.93% compared to CNY 5,894,683,430.01 in the same period of 2024[25] - Total operating costs increased to CNY 4,621,510,136.68, up 4.15% from CNY 4,437,216,451.83 in the previous year[26] Investment Activities - The company recognized an investment loss of CNY 36,714.58 million related to debt collection activities during the reporting period[9] - Cash inflow from investment activities totaled CNY 84,200,643,915.07, compared to CNY 30,159,815,409.30 in 2024, indicating a substantial increase[29] - Cash outflow from investment activities was CNY 82,650,721,863.70, up from CNY 32,091,767,455.80 in the previous year[29] Management Expenses - The company experienced a decrease in management expenses to CNY 1,631,108,133.82 from CNY 1,870,333,784.16, a reduction of 12.76%[26]